Skip to main content
. Author manuscript; available in PMC: 2019 Apr 18.
Published in final edited form as: N Engl J Med. 2018 Sep 16;379(16):1499–1508. doi: 10.1056/NEJMoa1800722

Figure 2. Cumulative Incidence of the Primary Composite End Point.

Figure 2.

Shown is the cumulative incidence of the primary composite end point (death from any cause, dementia, or persistent physical disability) according to trial group. First events that counted toward the primary end point during the trial included 911 deaths, 549 cases of dementia, and 375 cases of persistent physical disability. The graph stops at year 6 because only a small number of participants (44 in the aspirin group and 43 in the placebo group) reached year 7. The inset shows the same data on an enlarged y axis.